Results 41 to 50 of about 546,298 (344)

Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]

, 2020
: Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.

core  

Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease

Clinical and Applied Thrombosis/Hemostasis, 2021
Measurement of a single marker of coagulation may not provide a complete picture of hemostasis activation and fibrinolysis in patients with chronic cardiovascular diseases. We assessed retrospective orders of a panel which included prothrombin fragment 1.
Maureen J. Miller MD, MPH, Cheryl L. Maier MD, PhD, Alexander Duncan MD, Jeannette Guarner MD   +3 more
doaj   +1 more source

Innovative Implantable Left Ventricular Assist Device—Performance under Various Resistances and Operating Frequency Conditions

Applied Sciences, 2023
This paper presents the operation of an innovative left ventricular assist device under various resistances and operating frequencies. The operating principle of the device is based on pulsatile blood flow, which is forced by a suction–discharge device ...
Ryszard Jasinski, Krzysztof Tesch, Leszek Dabrowski, Jan Rogowski   +3 more
doaj   +1 more source

Recurrent Takotsubo Cardiomyopathy in a Patient With Hypertrophic Cardiomyopathy Leading to Cardiogenic Shock Requiring VA-ECMO

JACC: Case Reports, 2020
Providing hemodynamic support for patients with hypertrophic cardiomyopathy and cardiogenic shock can be challenging because inotropic medications worsen intraventricular obstruction, and the effect of appropriate mechanical support remains undefined. We
Mustafa Husaini, MD, Joshua N. Baker, MD, Sharon Cresci, MD, Richard Bach, MD, Shane J. LaRue, MD   +4 more
doaj   +1 more source

Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type

ESC Heart Failure, 2021
Continuous‐flow left ventricular assist devices (CF‐LVADs) have become a standard of care in end‐stage heart failure. Limited data exist comparing outcomes of HeartMate3 (HM3) and HeartWare HVAD (HW). We aimed to compare midterm outcomes of these devices.
Maks Mihalj, P. Heinisch, P. Schober, M. Wieser, M. Martinelli, T. D. de By, J. Schefold, M. Luedi, A. Kadner, T. Carrel, P. Mohacsi, L. Hunziker, D. Reineke   +12 more
semanticscholar   +1 more source

Ethical challenges with the left ventricular assist device as a destination therapy

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +1 more source

Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic Cardiomyopathy

Reviews in Cardiovascular Medicine, 2022
Echocardiography (ECHO) is indispensable for evaluation of patients with terminal chronic heart failure (HF) who require transplantation or mechanical circulatory support by a left- or biventricular assist device (LVAD or BiVAD, respectively).
Michael Dandel
doaj   +1 more source

Beneficial aspects of real time flow measurements for the management of acute right ventricular heart failure following continuous flow ventricular assist device implantation

Journal of Cardiothoracic Surgery, 2012
Background Optimal management of acute right heart failure following the implantation of a left ventricular assist device requires a reliable estimation of left ventricular preload and contractility.
Spiliopoulos Sotirios, Guersoy Dilek, Koerfer Reiner, Tenderich Gero   +3 more
doaj   +1 more source

Asistencia ventricular izquierda y reparación de drenaje venoso pulmonar anómalo parcial, como puente al trasplante cardiaco

Cirugía Cardiovascular, 2021
Resumen: Implantar asistencias ventriculares (AV) en situaciones anatómicas no convencionales asociadas a cardiopatía congénita puede constituir un problema para obtener un funcionamiento óptimo de la AV.
Carlos Nieto-Moral, Luz Polo-López, Raúl Sánchez-Pérez, Juvenal Rey-Lois, Álvaro González-Rocafort, Ángel Aroca-Peinado   +5 more
doaj   +1 more source

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J., Bruckner, Brian A., Chuang, Joyce, Estep, Jerry D., Farrar, David J., Haas, Donald C., Horstmanshof, Douglas A., Kasirajan, Vigneshwar, Lee, Sangjin, Long, James W., Milano, Carmelo A., Rogers, Joseph G., Selzman, Craig H., Shah, Keyur B., Starling, Randall C., Stehlik, Josef   +15 more
core   +2 more sources